Earnings Releases·Nov 4, 2026, 4:10 PM ET

Acadia Healthcare — Third Quarter 2026 Earnings Summary

Total revenue increased 5.1% year-over-year to $895.3 million, while net income and adjusted net income declined to $34.5 million ($0.38/share) and $54.6 million ($0.60/share) respectively, driven by a 6.4% rise in operating expenses.
Full-year 2026 guidance was raised across all key metrics: revenue to $3.44–$3.46 billion, adjusted EBITDA to $615–$625 million, and adjusted EPS to $1.70–$1.80, alongside a lowered capex guidance of $210–$230 million.
Segment performance showed a 11.3% revenue increase in acute inpatient facilities due to capacity expansion, offset by an 8.2% decline in specialty treatment facilities resulting from closures in Pennsylvania.
The company added 220 licensed beds during the quarter, holds $163.3 million in cash with $710.1 million available under its credit facility, and maintains a net leverage ratio of 3.9x.
No major acquisitions or share repurchases occurred during the quarter, though management noted a favorable $13.4 million benefit from Florida supplemental payments included in adjusted EBITDA.